Search
ATAI Life Sciences NV
ATAIAdd to Watchlist
4.880USD
-0.390-7.40%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.80BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-7.40%
5 Days
+17.03%
1 Month
+1.24%
6 Months
+19.32%
Year to Date
+19.32%
1 Year
+80.07%
Key Figures
5.230Open
5.260High
8.21MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.26%Turnover Ratio
5.270Prev. Close
4.800Low
27.57MTurnover
LossP/E Static
7.99P/B
0.00%Div Yield TTM
-288.06%ROA
6.75052wk High
0.42Volume Ratio
-149.27MNet Profit
363.28MShares
-2.8471EPS TTM
1.60Beta
-378.29%ROE
2.00052wk Low
8.73%Amplitude
100.00%Gross Margin
1.80BMarket Cap
2.12Reward/Risk
4.52%Risk Rate
TradingKey Stock Score of ATAI Life Sciences NV
Currency: USD Updated: 2026-07-01Key Insights
ATAI Life Sciences NV's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 118 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.83.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ATAI Life Sciences NV's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
ATAI Life Sciences NV Highlights
StrengthsRisks
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 1202.23% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.09M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.09M.
Overvalued
The company’s latest PE is -1.71, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 73.07M shares, increasing 24.28% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 2.71M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.17.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
13.833
Target Price
+162.49%
Upside Space
ATAI Life Sciences NV News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ATAI Life Sciences NV Info
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
Ticker SymbolATAI
CompanyATAI Life Sciences NV
CEORao (Srinivas G)
Websitehttps://www.atai.com/
Related Instruments
-0.64%
-0.05%
-0.23%
-1.64%
-2.41%
-2.95%
-0.22%
+1.75%
-0.29%
-0.79%
+0.26%
-2.00%
-2.10%
-2.41%
+1.68%
0.00%
+0.19%
-1.97%
+0.06%
-0.44%Popular Instruments
52269.200
+14.900 (+0.03%)
29649.000
-150.300 (-0.50%)
7473.600
-1.900 (-0.03%)
14790.000
-565.000 (-3.68%)
68484.000
-1001.000 (-1.44%)
6286.900
+11.500 (+0.18%)
68.014
+0.046 (+0.07%)
294.380
+5.020 (+1.73%)
197.580
-2.510 (-1.25%)
4071.860
+41.090 (+1.02%)
FAQs
What is the current price of ATAI Life Sciences NV (ATAI)?
The current price of ATAI Life Sciences NV (ATAI) is 4.88.
What is the symbol of ATAI Life Sciences NV?
The ticker symbol of ATAI Life Sciences NV is ATAI.
What is the 52-week high of ATAI Life Sciences NV?
The 52-week high of ATAI Life Sciences NV is 6.75.
What is the 52-week low of ATAI Life Sciences NV?
The 52-week low of ATAI Life Sciences NV is 2.00.
What is the market capitalization of ATAI Life Sciences NV?
The market capitalization of ATAI Life Sciences NV is 1.77B.
Is ATAI Life Sciences NV (ATAI) currently rated as Buy, Hold, or Sell?
According to analysts, ATAI Life Sciences NV (ATAI) has an overall rating of Buy, with a price target of 13.83.
What is the Earnings Per Share (EPS TTM) of ATAI Life Sciences NV (ATAI)?
The Earnings Per Share (EPS TTM) of ATAI Life Sciences NV (ATAI) is -2.91.